Physician profile
David E Virgil
NPI 1598175747
$3,756.05
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,864 · 2020: $336 · 2021: $343 · 2022: $566 · 2023: $296 · 2024: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $627.30 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $579.19 | 2019-2021 | |
| Lilly USA, LLC | $533.14 | 2019-2023 | Mounjaro, Trulicity |
| Abbott Laboratories | $480.67 | 2019-2024 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.31 | 2019-2020 | |
| Boston Scientific Corporation | $312.14 | 2020-2024 | Watchman Flx |
| Amgen INC. | $302.97 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $214.53 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.23 | 2023 | Lifevest |
| Merck Sharp & Dohme LLC | $120.27 | 2019 | |
| Pfizer INC. | $56.70 | 2019-2020 | |
| Edwards Lifesciences Corporation | $36.30 | 2019 | |
| Hologic Sales and Service, LLC | $17.30 | 2024 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Virgil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.